Overall rank by patents
#46,806
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 7 technology areas, active 2018–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
Fundación holds 5 US patents across 7 technology areas, rank #46,806 of 50,000 tracked assignees.
Fundación PARA EL Fomento DE LA Investigación Sanitaria Y Biomédica DE LA Comunitat Valenciana has been granted 5 US utility patents between 2018 and 2024, placing Fundación PARA EL Fomento DE LA Investigación Sanitaria Y Biomédica DE LA Comunitat Valenciana at rank #46,806 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a Foreign Corporation, Fundación PARA EL Fomento DE LA Investigación Sanitaria Y Biomédica DE LA Comunitat Valenciana is one of the more focused assignees in the PatentsView dataset. By volume, Fundación sits between Fundacao DE Amparo A Pesquisa DO Estado DE Minas Gerais—fapemig (5 patents, rank #46,802) and FUSE Chicken, Llc (5 patents, rank #46,810) - the closest US assignees by grant volume. The composite Innovation Score of 29.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 2 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fundación PARA EL Fomento DE LA Investigación Sanitaria Y Biomédica DE LA Comunitat Valenciana's 11.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fundación PARA EL Fomento DE LA Investigación Sanitaria Y Biomédica DE LA Comunitat Valenciana against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
FUNDACAO DE AMPARO A PESQUISA DO ESTADO DE MINAS GERAIS—FAPEMIG
5 patents
FUNDACIÓ INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU
5 patents
FUNDACIÓ PER A LA UNIVERSITAT OBERTA DE CATALUNYA
5 patents
FUNDACIÓN DEL SECTOR PÜBLICO ESTATAL CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS CARLOS II
5 patents
FUNOOGLES, LLC
5 patents
FUNPEP CO., LTD.
5 patents
FUSCO INDUSTRIAL CORPORATION
5 patents
FUSE CHICKEN, LLC
5 patents
FUNDACIÓN PARA EL FOMENTO DE LA INVESTIGACIÓN SANITARIA Y BIOMÉDICA DE LA COMUNITAT VALENCIANA
5 patents
What this shows Fundación holds 5 patents at rank #46,806, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #46,806 in granted patent volume.
Other assignees with the most granted patents in Fundación's primary technology class.
Fundación's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 71% higher than 29% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 20.0% |
| 2019 | 1 | 20.0% |
| 2021 | 1 | 20.0% |
| 2023 | 1 | 20.0% |
| 2024 | 1 | 20.0% |
Top 7 of 7 technology areas
Overall rank by patents
#46,806
Across all tracked assignees
29.1 out of 100
How to use this portfolio
Fundación's 5 grants land it in the top 71% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.